NEW YORK — The US Food and Drug Administration on Wednesday issued separate Emergency Use Authorizations for molecular SARS-CoV-2 tests developed by Cue Health, Tide Laboratories, and TBG Biotechnology.
NEW YORK — The US Food and Drug Administration on Wednesday issued separate Emergency Use Authorizations for molecular SARS-CoV-2 tests developed by Cue Health, Tide Laboratories, and TBG Biotechnology.
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.
Don't have a 360Dx or GenomeWeb account?
Register for Free.